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Oral vaccine failureBackground: Environmental enteropathy (EE) is a subclinical enteric condition found in low-income countries
that is characterized by intestinal inﬂammation, reduced intestinal absorption, and gut barrier dysfunction. We
aimed to assess if EE impairs the success of oral polio and rotavirus vaccines in infants in Bangladesh.
Methods: We conducted a prospective observational study of 700 infants from an urban slum of Dhaka,
Bangladesh from May 2011 to November 2014. Infants were enrolled in the ﬁrst week of life and followed to
age one year through biweekly home visits with EPI vaccines administered and growthmonitored. EE was oper-
ationally deﬁed as enteric inﬂammationmeasured by any one of the fecal biomarkers reg1B, alpha-1-antitrypsin,
MPO, calprotectin, or neopterin. Oral polio vaccine successwas evaluated by immunogenicity, and rotavirus vac-
cine response was evaluated by immunogenicity and protection from disease. This study is registered with
ClinicalTrials.gov, number NCT01375647.
Findings: EE was present in greater than 80% of infants by 12weeks of age. Oral poliovirus and rotavirus vaccines
failed in 20.2% and 68.5% of the infants respectively, and 28.6%weremalnourished (HAZ b−2) at one year of age.
In contrast, 0%, 9.0%, 7.9% and 3.8% of infants lacked protective levels of antibody from tetanus, Haemophilus
inﬂuenzae type b, diphtheria and measles vaccines respectively. EE was negatively associated with oral polio
and rotavirus response but not parenteral vaccine immunogenicity. Biomarkers of systemic inﬂammation and
measures of maternal health were additionally predictive of both oral vaccine failure and malnutrition. The se-
lected biomarkers from multivariable analysis accounted for 46.3% variation in delta HAZ. 24% of Rotarix® IgA
positive individuals can be attributed to the selected biomarkers.
Interpretation: EE as well as systemic inﬂammation and poor maternal health were associated with oral but not
parenteral vaccine underperformance and risk for future growth faltering. These results offer a potential expla-
nation for the burden of these problems in low-income problems, allow early identiﬁcation of infants at risk,
and suggest pathways for intervention.
Funding: The Bill and Melinda Gates Foundation (OPP1017093).
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Environmental enteropathy (EE) is a subclinical yet apparently com-
mon illness in low income countries that is characterized by small intes-
tine inﬂammation with shortened villi, intestinal barrier dysfunction,
and reduced nutrient absorption (Korpe and Petri, 2012; Campbellhool of Medicine, Division of
le VA 22908-1340, USA.
. This is an open access article underet al., 2003; McKay et al., 2010). EE is associated with poverty and un-
sanitary living conditions, and hypothesized to be caused by repeated
or chronic exposure to enteropathogens and by malnutrition (Korpe
and Petri, 2012).
EE in turn is suspected to contribute to the development ofmalnutri-
tion and hinder its treatment, via small intestinal damage and resulting
inﬂammation (Korpe and Petri, 2012; Prendergast and Kelly, 2012).
Vaccines against enteric pathogens such as rotavirus and poliovirus
have shown lower efﬁcacy in developing countries, particularly in mal-
nourished populations (Haque et al., 2014; Levine, 2010; Grassly et al.,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Anthropometry over the ﬁrst 52 weeks of life. Height and weight were taken at
scheduled clinic visits, and transformed to standardized z-scores. The X axis depicts the
age of the child, the Y axis depicts the percentage of infants in the cohort who had a
HAZ, WAZ, or WHZ of b−2.
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be adversely affected by EE.
The primary objective of the PROVIDE study was to test the hypoth-
esis that there is an association between EE and impaired performance
of the oral polio vaccine (OPV) and rotavirus vaccine in Bangladesh. A
set of fecal proteins were used as biomarkers to noninvasively measure
EE surrounding the time of vaccination. Myeloperoxidase, calprotectin,
and neopterin were chosen to represent enteric inﬂammation, while
alpha-1 anti-trypsin and reg1B were chosen to represent compromised
intestinal epithelial integrity. In addition, biomarkers of nutrition and
systemic inﬂammation, socioeconomic status, and maternal health
were measured. Nutritional status was assessed by micronutrients and
anthropometry measurements. Systemic inﬂammation was evaluated
with inﬂammatory and regulatory cytokines, acute phase proteins
(CRP, ferritin), and sCD14 (Supplemental Table 1). The primary out-
comes were OPV serum neutralizing antibody titers and Rotarix® IgA
titer, and Rotarix® success. Antibody titers were evaluated as a contin-
uous variable. Secondary outcomes were growth as measured by HAZ
and WAZ over one year.
2. Methods
2.1. Study Design
The study design and recruitment of the PROVIDE cohort has been
described previously (Kirkpatrick et al., 2015a; Kirkpatrick et al.,
2015b). In brief, a birth cohort of 700 infants from the Mirpur urban
slum in Dhaka, Bangladeshwere recruited and followed by twiceweek-
ly household visits and scheduled clinic visits over the ﬁrst 2 years of
life. All EPI-approved vaccines were administered by the study staff,
and half of the infantswere randomized to receive the Rotarix® vaccine.
Therewas rolling admission of subjects over the ﬁrst 18months and the
study spanned from May 2011–November 2014. The study was ap-
proved by the Ethical Review Board of the ICDDR,B (FWA 00001468)
and the Institutional Review Boards of the University of Virginia (FWA
00006183) and the University of Vermont (FWA 00000727). The
PROVIDE cohort data has been utilized to assess Rotarix® efﬁcacy
(Kirkpatrick et al., 2015b).
2.2. Biomarker Selection and Deﬁnition
Biomarkersmeasuredwere selected to report on environmental fac-
tors postulated to affect nutrition and vaccine response: enteric inﬂam-
mation, systemic inﬂammation, nutrition, socioeconomics, maternal
health, and sanitation (Supplemental Table 1). These groupings did
not affect the outcome of the statistical results.
2.3. Measurement of Vaccine Response and Malnutrition
Vaccine immunogenicity was measured in plasma at 18 and/or
52 weeks of age, and Rotarix® success was measured as protection
from rotavirus diarrhea from weeks 18–52 in vaccinated infants
(Supplemental Table 2). Height and weight were measured at enroll-
ment and at every clinic visit using a Seca 354 Digital Baby Scale and
Seca 416 Infantometer. Weight for age (WAZ), weight for height
(WHZ), and height for age (HAZ) were measured using the WHO
Multicenter Growth Reference Study Child Growth Standards (The
World Health Organisation, the United Nations Children's Fund's,
2009). The change in HAZ and WAZ was calculated by subtracting the
enrollment from the 52 week values.
2.4. Statistical Methods
Univariate linear or logistic regression analyses for continuous or bi-
nary responses (Rotarix® success only) were performed to evaluate the
marginal effect of individual biomarker on the responses. FalseDiscovery Rate (FDR) was used to correct for multiple comparisons
with potentially informative biomarkers identiﬁed with a 20% FDR cut-
off. Multivariable regression analysis with the Smoothly Clipped Abso-
lute Deviation (SCAD) regularization was conducted to identify
predictive biomarkers jointly, and the ﬁnal model for each response
was determined based on the optimal tuning parameter using 10-fold
cross-validation criteria. Given several dozens of available biomarkers
as potential predictors, traditional variable selection methods such as
stepwise regressionmaynot be practical or less efﬁcient.Modern penal-
ized regression methods, such as LASSO (Least Absolute Shrinkage and
Selection Operator) or SCAD, can effectively identify the subset of bio-
markers that are truly informative for the responses of interest
(Tibshirani, 1996; Fan and Li, 2001). By imposing some penalty in the
regressionmodel ﬁtting, these penalizedmethods can shrink the coefﬁ-
cients of those unimportant biomarkers to zero while retain those im-
portant ones. Note that a biomarker has an effect on a response if and
only if its coefﬁcient is nonzero. Thus the ﬁnal models shall include all
important biomarkers with parsimonious representation, enhanced in-
terpretability, and improved prediction precision. The SCAD method
was used in this study for its better statistical properties of variable se-
lection and parameter estimation. All the SCAD analyses were per-
formed using the “grpreg” package in R 3.1 (www.r-project.org). In
addition, the hierarchical clustering analysis of biomarkers was per-
formed to classify and present biomarkers graphically according to
their correlated structure and similarity patterns. The function
“hclustvar” in the R package “ClustOfVar” was used in the clustering
analysis (www.r-project.org). The method can accommodate a mixture
of quantitative and qualitative variables and classify those strongly cor-
related or similar biomarkers into the same clusters using homogeneity
criterion (Chavent et al., 2011). Besides clustering analysis and multi-
variable analysis with SCAD as indicated, all other statistical analyses
were performed using SAS 9.3 (SAS Institute; Cary, NC).3. Results
3.1. Characteristics of the Cohort
At enrollment the average age was 4.9 days of age, average HAZ and
WAZ were−0·90 and−1·29 respectively. 28.9% of mothers were illit-
erate. Averagemonthly family incomewas 13,000 Taka (169 US dollars).
Breastfeeding was nearly universal up to one year of age, with an exclu-
sive breastfeeding taking place for an average 120 days. Over the ﬁrst
year of life infants with stunting (HAZ b−2) increased from 9.5% at en-
rollment to 27.6%, with 22% of the infants underweight (WAZ b−2) and
7.4% wasted (WHZ b−2) at week 52 (Fig. 1).
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Stool samples at 12weeks of agewere analyzed for biomarkers of EE.
Fecal measures myeloperoxidase (MPO) and calprotectin, markers of
neutrophil inﬂammation and biomarkers of inﬂammatory bowel dis-
ease, were abnormal in 82% and 94% of the infants respectively. Fecal
alpha-1-antitrypsin was also elevated in 82% of the infants (Fig. 2). We
concluded that the majority of the infants had evidence of enteric in-
ﬂammation by 12 weeks of age.
3.3. Clustering Analysis of the Biomarkers
The relationships among biomarkers were explored by a cluster
analysis. There were three major clusters among all the biomarkers
(Fig. 3). Cluster 1 included days of diarrhea through week 18 and was
dominated by systemic inﬂammatory biomarkers, particularly plasma
cytokines and the acute phase reactant ferritin; mannitol absorption
was also in this cluster. Cluster 2 contained all of the biomarkers consid-
ered evidence of enteric inﬂammation (fecal reg1B, alpha-1-antitrypsin,
MPO, calprotectin, and neopterin),micronutrients, and two systemic in-
ﬂammatory biomarkers, sCD14 and CRP (potentially reﬂecting bacterial
translocation from the gut). Two of the four sanitation markers (the ab-
sence of an open sewer and access to a toilet/septic tank) were also in
Cluster 2. Cluster 3 comprised maternal health biomarkers including
mother's height, weight, and education, HAZ at 18weeks, and socioeco-
nomic measures including income, access to treated water, and no
shared toilet. The intestinal regeneration biomarker fecal reg1B at
6 weeks of age was also present in cluster 3.
3.4. EE Was Associated With OPV and Rotarix® Underperformance
and Failure but Not Parenteral Vaccine Underperformance and With
Malnutrition
Based on the results from the cluster analysis, reg1B, calprotectin,
neopterin,MPO, and alpha-1 antitrypsinwere considered as biomarkers
of EE. Biomarkers of EE measured during the time of vaccination were
tested by multivariable analysis for association with outcomes of vac-
cine response and nutrition. EE was associated with the infants' re-
sponse to OPV2 (fecal reg1B), OPV3 (fecal reg1B and calprotectin),
Rotarix® IgA (fecal alpha-1-antitrypsin), and Rotarix® success (fecal
reg1B and neopterin) (Table 1).While other biomarkers on cluster 2 as-
sociated with these parenteral-administered vaccines, biomarkers of EE
were not associatedwith the response to the vaccines tetanus, pertussis,
diphtheria, Haemophilus inﬂuenza type B and measles (Table 1). EE bio-
markers fecal reg1B and MPO were also negatively associated with
changes in WAZ and HAZ from enrollment to age one year (Table 1).
Univariate analysis also revealed that markers of enteric inﬂammation,Fig. 2. Environmental enteropathy in infants. Frequency distribution of fecal calprotectin, myelo
normal values, and white columns represent abnormal values. Normal valueswere based onW
(88.1% elevated), alpha-1 anti-trypsin is N270 μg/g (81.9% elevated). Calprotectin n = 596, MPincluding the EE biomarkers, associated with change in WAZ and HAZ
(Fig. 4).
Not every biomarker of EE was selected by multivariable analysis,
likely due to the fact that they were clustered, but notably reg1B was
predictive of OPV2, OPV3, and Rotarix® success. Univariate analysis,
likely by virtue of only considering the marginal effect, revealed fewer
EE biomarkers than the multivariable SCAD analysis that considered
the joint effect (Fig. 4). One biomarker postulated to be a measure of
EE, the lactulose:mannitol ratio, was unable to be measured in this co-
hort due to a naturally occurring substance in the urine of infants that
co-eluted with lactulose on HPIC (data not shown).
3.5. Systemic Inﬂammation Was Associated With Oral and Parenteral
Vaccine Response and With Malnutrition
As opposed to fecal EE biomarkers, systemic inﬂammatory markers
were associated with parenteral and oral vaccine responses, as well as
with nutrition bymultivariable analyses. Cluster 1 systemic biomarkers
and their associated vaccine outcomes were: ferritin (OPV2, tetanus,
pertussis, diphtheria ΔWAZ, ΔHAZ), IL-10 (Rotarix® IgA), activin
(diphtheria), and IL-1b (ΔWAZ) (Table 1). CRP (pertussis, ΔWAZ) and
sCD14 (OPV1, measles, tetanus, Rotarix® success, ΔHAZ) from cluster
2 were also associated with some outcomes. Many of the systemic bio-
markers identiﬁed were positively associated with parenteral vaccine
response, as opposed to the negative association with oral vaccine and
nutrition.
3.6. Nutritional Status at the Time of VaccinationWas AssociatedWith Oral
and Parenteral Vaccine Response
Multivariable analysis demonstrated thatmalnutrition at the time of
vaccination, as measured by WAZ, HAZ and/or WHZ, affected the re-
sponse to every vaccinemeasuredwith the exception of Rotarix®,mea-
sles and OPV1. Not unexpectedly, 18 week nutritional status predicted
that at one year of life (Table 1). Biomarkers of micronutrients were
also associated with vaccine response, including retinol binding protein
(RBP), zinc and ferritin for OPV2 and RBP, zinc and vitamin D for
Rotarix®, and RBP and ferritin for tetanus. Change in HAZ and WAZ in
turn was associated with RBP, vitamin D, zinc, and ferritin (Table 1).
3.7. Maternal Height and Weight Were Not Associated With Vaccine
Response
While maternal malnutrition, as measured by height and weight, is
known to predict infant malnutrition (as was the case for this study),
this was not generally true for vaccine response, with only tetanus
linked to maternal weight by multivariable analysis (Table 1);peroxidase, and alpha-1 anti-trypsin at age 12weeks using ELISA. Black columns represent
estern standards: calprotectin N 200 μg/g (82.7% elevated), myeloperoxidase N 2000 ng/ml
O n = 591, alpha-1 anti-trypsin n = 592.
Fig. 3. Cluster dendrogram of biomarkers. Biomarkers are clustered according to relatedness; adjacentmarkers are themost closely correlated, while increased distance indicates decreas-
ing correlations. Biomarker clusters are numbered 1 (systemic inﬂammation), 2 (enteric inﬂammation and malabsorption), and 3 (maternal health).
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association with OPV3 (Fig. 4).
3.8. Quantiﬁable effect of biomarkers on Rotavirus and Malnutrition
Biomarkers selected by SCADwere analyzed for the ability to explain
the variation seen in ΔHAZ and rotavirus vaccine-induced plasma IgA
through evaluation of the attributable fraction of variance. For Rotarix®
IgA the percent variance explained was approximately 24% while for
ΔHAZ the biomarkers selected by multivariable analysis explained
46·3% of the observed variation.
To further understand the effect of EE during the ﬁrst year of life, CRP
elevation was evaluated for effect on change in HAZ from 0–52 weeks.
CRP, a systemic inﬂammation biomarker that clusters with the EE bio-
markers, was measured in the cohort at 6, 18, and 40 weeks, making it
an ideal marker of sustained inﬂammation. Infants were classiﬁed into
four groups: Group 0 consisted of those infants if none of their CRPs
were elevated, Group 1 if one CRP measure was elevated, Group 2 if
two CRPs were elevated and Group 3 if all three CRPs were elevated.
Group 0 was considered as the reference in this analysis. Infants were
found to be signiﬁcantly more likely to have a negative change in HAZ
if CRP was elevated at 2 or more time points (Table 2).
4. Discussion
This prospective longitudinal study of infants in an urban slum
from Bangladesh enabled analysis of the impact of EE at the time of vac-
cination on EPI vaccine response and nutrition. The most important
ﬁnding was that EE was associated with failure of Rotarix® and
underperformance of OPV but had no impact on the immunogenicity
of theparenteral-administered EPI vaccines.Malnutritionwas also asso-
ciated with EE. The identiﬁcation of EE as predictive of OPV and
Rotarix®underperformance andmalnutritionwas all themore remark-
able for the fact that over 80% of infants had EE, with over half demon-
strating sustained inﬂammation associated with EE. That oral vaccine
underperformance andmalnutrition were both associated with EE sug-
gests that gut damage induced by EE is common to their pathogenesis.4.1. Three Pathways Affecting Vaccine Response and Growth
The clustering of biomarkers (Fig. 3) immediately suggested interre-
lated responses to environmental stressors (Fig. 5),with gut damage, in-
ﬂammation, and maternal health as underlying processes common to
oral vaccine failure and stunting.
Cluster 1 was comprised predominantly of markers of systemic in-
ﬂammation and diarrheal disease. Diarrhea has been previously associ-
ated with growth faltering and OPV failure (Haque et al., 2014; Richard
et al., 2013;Mondal et al., 2009;Myaux et al., 1996; Richard et al., 2014)
and our work suggests this may be due in part to the development of
systemic inﬂammation. We hypothesize that systemic inﬂammation
as a result of diarrheal disease could contribute to oral vaccination
underperformance by inhibiting attenuated live virus replication due
to up-regulated antiviral responses. Systemic inﬂammation could con-
tribute to malnutrition by activation of the anorexia-inducing activin-
myostatin pathway (Han et al., 2013) as well as by consuming energy
which otherwise could be used for growth. Ferritin levelswere also neg-
atively associatedwith growth. Ferritin is an acute phase protein and el-
evated levels likely indicate the presence of active infection; it is also
possible that ferritin's role iron sequestration as a defense against path-
ogen assault results in reduced free iron for growth requirements
(Wang et al., 2010).
Cluster 2 biomarkers included the EE biomarkers of gut damage and
inﬂammation, as well as micronutrients, consistent with EE being asso-
ciated with gut dysfunction. We previously had demonstrated that in-
testinal damage predicted growth faltering in infants in Bangladesh
and Peru, asmeasured by fecal reg1B (Peterson et al., 2013). The current
work validated and extended this observation by showing that oral vac-
cine underperformance and failure was also associated with enteric in-
ﬂammation and damage. While unable to diagnose environmental
enteropathy directly by small bowel biopsy, noninvasive measures in
stool of epithelial damage (reg1B and alpha-1 antitrypsin), and enteric
immune inﬂammation (myeloperoxidase, calprotectin, and neopterin)
served as surrogates. These biomarkers were tightly clustered,
supporting their use as measures of EE. Previous studies focused on nu-
trition but not vaccine response found that increased fecal alpha-1 anti-
trypsin, MPO and neopterin were associated with linear growth defects
Table 1
SCADa-selected biomarkers and coefﬁcients. Direction of association is indicated by (+) or (−) next to biomarker name. Vaccination “outcome” refers to the detectable antibody titer of
the indicated vaccine.
Outcomes Cluster 1 biomarkers Cluster 2 biomarkers Cluster 3 biomarkers
ΔHAZ
(n = 498)
Days of diarrhea (−) Reg1B week 12 (−) Expenditure (+)
Mannitol (−) MPO (−) Maternal height (+)
Ferritin week 18 (−) CRP week 6 (−) Access to treated water (+)
sCD14 week 6 (−) RBP week 6 (+) vitamin D (−) Zinc (−) WAZ week 18 (+)
ΔWAZ
(n = 498)
Ferritin week 18 (−) Reg1B week 12 (−) Maternal education (+)
IL-1β (2) (−) MPO week 12 (−) Maternal weight (+)
IL-1β (3) (−) CRP week 6 (−) Access to treated water (+)
Exclusive breastfeeding (−) HAZ week 18 (+)
Zinc week 6 (−) WHZ week 18 (+)
OPV1
(n = 509)
sCD14 week 6 (−)
sCD14 week 18 (+) Maternal education (+)
OPV2
(n = 509)
Ferritin week 6 (−) RBP week 6 (+)
Zinc week 6 (+) Reg1β week 6 (−)
Access to Septic tank/toilet (+) WAZ week 18 (+)
OPV3
(n = 509)
Mannitol week 12 (−) Reg1βweek 12 (−)
Calprotectin week 12 (+) Maternal height (+)
WHZ week 18 (+)
Rotarix IgA
(n = 261)
IL-10 (2) (−) Alpha-1 anti-trypsin (−)
IL-10 (3) (+) Exclusive breastfeeding (−)




Male (−) Reg1βweek 12 (+) Reg1β week 6 (+)
Neopterin week 12 (−) Maternal education (+)
sCD14 week 6 (−)
RBP week 6 (−)
Vitamin D week 18 (−)




Days of diarrhea (+) Endocab week 18 (+) WAZ week 18 (+)
IL-6 (2) (+) sCD14 week 18 (+)
IL-6 (3) (+) RBP week 6 (+)




Ferritin week 6 (+) sCD14 week 18 (−) Maternal weight (+)
Expenditure (+)
WAZ week 18 (+)
Pertussis—Ptx
(n = 481)
Ferritin week 6 (+) CRP week 18 (−) Maternal weight (+)
Exclusive breastfeeding (+) Income (+)
WHZ week 18 (+)
Diphtheria
(n = 481)
Ferritin week 6 (+) WAZ week 18 (+)
Activin week 6 (+)
HiB
(n = 481)
Days of diarrhea (+) Septic tank/toilet (−) WAZ week 18 (+)
Mannitol week 12 (−) WHZ week 18 (+)
Measles
(n = 481)
Endocab week 6 (−)
sCD14 week 6 (+)
sCD14 week 18 (−)
RBP week 18 (−)
Vitamin D week 6 (+)
a Smoothly Clipped Absolute Deviation (SCAD)was applied for the multivariable analysis to identify a small subset of important biomarkers. SCAD imposes a penalty in the regression
model to shrink small coefﬁcients of unimportant biomarkers to zero and retain important biomarkers in the model, simultaneously producing coefﬁcient estimates for the selected
biomarkers.
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also on cluster 2, consistent with environmental enteropathy-induced
malabsorption which would further lead to growth faltering and poor
immune function (Korpe and Petri, 2012; Richard et al., 2014; Han
et al., 2013).
Cluster 3 represents a pathway centered on the health and socioeco-
nomic status of the mother. Maternal height and nutrition is known to
be associated with child mortality and growth, an association not seen
with paternal height (Ozaltin et al., 2010; Di Cesare et al., 2015). Novel
to this study was the ﬁnding that cluster 3 was associated with OPV1
(maternal education) and tetanus (maternal weight). Children born to
short mothers are signiﬁcantly more likely to have a low birth-weight,
become stunted, and to die before ﬁve years of age (Black et al., 2008).
Intrauterine nutrient availability aswell as transgenerational epigenetic
effects (Dominguez-Salas et al., 2014;Wu et al., 2004) could act to affect
a child's nutritional status. Additionally, the educational status of
women has been found to have twice the effect of that of males educa-
tion on a child's overall health (Christiaensen and Alderman, 2004).
Strikingly, the EE biomarkers associated with oral vaccine under-
performance and malnutrition did not associate with parenteralvaccine performance. Parenteral vaccine biomarkers were instead
composed mainly of nutritional and systemic inﬂammatory bio-
markers. Measles displayed variable directional associations. While
univariate analysis revealed associations in all clusters, the strongest
associations were seen in cluster 2, a result complimented by the
SCAD selection. In common with the other parenteral vaccines there
was no association of any enteric inﬂammation biomarkers. Instead,
associations are strongest with micronutrients and acute phase pro-
teins. In contrast to oral vaccine response, RBP had a negative effect
on measles antibody response. The effect of vitamin A on measles se-
roconversion is unclear, with at least one paper demonstrating a neg-
ative effect(Garly and Aaby, 2003). Our results would support this,
though it is important to keep in mind that RBP is a surrogate marker
for vitamin A. The seemingly contradictory associations of measles
antibody titer to the biomarkers could be due to the genetic compo-
nent of measles vaccine response. There are high levels of heritability
in vaccine response, with HLA alleles strongly affecting the humoral
response (Jacobson and Poland, 2004). Underlying genetic control of
measles antibody titer could cause interference in the analyses used
in this study.
Fig. 4.Heatmap of FDR values from univariate linear regression analysis. Biomarkers with a FDR value of 0.2 or below for at least one outcome are depicted on the heatmap. Markers are
grouped according to hierarchal cluster results. A positive correlation is indicated by a blue box, and a negative correlation is indicated by a red box. Color patterns reveal associations of
biomarkers with outcomes, indicating an improvement or worsening of response. An FDR value close to 0 indicates a strong correlation. Color intensity is indicative of FDR value: darker
colors are closer to 0.
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markers from each of the three clusters. EE and systemic inﬂammation
biomarkers had negative associations with growth; this result indicates
that localized enteric inﬂammatory damage and broad systemic inﬂam-
mation both are likely to have an important effect on nutritional status.
Maternal healthwas also identiﬁed as particularly important for tetanus
vaccine response and child nutrition, with improved maternal health
correlating with improved child growth. The SCAD analysis is of partic-
ular importance as the identiﬁcation of biomarkers for vaccine response
and nutrition representing enteric inﬂammation, systemic inﬂamma-
tion, and maternal nutrition, suggests three areas of potential interven-
tion and monitoring.
This study had several limitations.Most importantly it was an obser-
vational study and therefore unable to demonstrate causality. Further,Table 2
Comparison of ΔHAZ by elevated CRP groups.
CRP groupa No. of children (%) ΔHAZ P valueb
Group 0: no elevated CRP 102 (17.9) −0.40 ± 0.96 Reference
Group 1: one elevated CRP 178 (31.2) −0.47 ± 0.88 0.54
Group 2: two elevated CRPsc 186 (32.6) −0.65 ± 0.86 0.02
Group 3: three elevated CRPsc 104 (18.2) −0.75 ± 0.86 0.005
a CRP was measured at weeks 6, 18 and 40 with median (25th to 75th quartile) as 0.24
(0.06 to 0.56), 0.62 (0.21 to 1.65), and 0.98 (0.20 to 3.42), respectively. An elevated CRP
was deﬁned as if the CRP measure was above the median for the week being measured.
b Pairwise P-values from one-way ANOVA, where the differences of ΔHAZ among the
four CRP groups were compared with Group 0 (the reference).
c Sustained inﬂammation with respect to CRPs was deﬁned as if at least two CRP mea-
sures were elevated. Signiﬁcantly greater HAZ reductions were observed in children with
sustained inﬂammationwhen compared to thosewith one or zero elevated CRP (pairwise
P value = 0.04 and 0.009 for Groups 2 and 3, respectively).the study population was exclusively from a low-income urban slum
where EE by our working deﬁnition was near universal. Comparison
to healthy infants from a higher socioeconomic class in Dhaka could
add to the understanding of EE impact on child health. The statistical
analysis focused on linear relationships; it is possible that some of the
biomarkers measured have a more complex relationship with the out-
comes. Finally, the gold-standard tests for EE, the lactulose:mannitol
ratio and biopsies, could not be used due to the very young age of our
study cohort. However, combining the observations of previous re-
search on EE with accepted tests for enteric inﬂammation, the
study has broken signiﬁcant new ground by developing a working def-
inition of EE and demonstrating its importance in oral vaccine
underperformance and failure.
5. Conclusions
EE was associated with Rotarix® failure and underperformance of
OPV and predicted the development of malnutrition. Understanding
the triggers of environmental enteropathy and designing interventions
to prevent or treat it are therefore of immense importance. EE is unique-
ly seen in settings with high exposure to enteric pathogens, malnutri-
tion and poor sanitation (Korpe and Petri, 2012; Prendergast and
Kelly, 2012; Keusch et al., 2014; Guerrant et al., 2008). The absence of
diarrhea on cluster 2 that contains the EE biomarkers leads us to postu-
late that asymptomatic enteric infection may contribute to environ-
mental enteropathy. Infants in Dhaka, Bangladesh as young as one
month have been found on average to have two enteric pathogens pres-
ent in stool samples even without overt diarrhea (Taniuchi et al., 2013).
It is possible that such subclinical infections could be causing a chronic
innate immune activation localized to the gut. Within cluster 2 were
Fig. 5. Proposed pathways to oral vaccine underperformance and failure and malnutrition. Potential mechanisms are shown by which the three biomarker clusters [(1) systemic inﬂam-
mation, (2) enteric inﬂammation, and (3) maternal health] could impact oral vaccines and nutrition.
1765C. Naylor et al. / EBioMedicine 2 (2015) 1759–1766also the sanitation markers reporting proximity to an open drain or the
availability of a septic tank toilet; as for enteric inﬂammation bio-
markers, it is interesting that these do not clusterwith diarrheal burden.
This clustering further supports the hypothesis that low-level exposure
to pathogens drives enteric inﬂammation.
These results are of signiﬁcance at the level of public health. Inter-
ventions focusing on EE, systemic inﬂammation, and improvement of
maternal health could be predicted to make an impact on child health
through improved oral vaccine response and nutrition.We have discov-
ered that oral vaccine failure is likely the result of some of the same
pathological processes that drive malnutrition, increasing the need for
multifaceted interventions. The identiﬁcation of systemic and enteric
inﬂammatory clusters emphasizes the necessity ofmulti-pronged inter-
vention strategies to EE to fully address malnutrition and oral vaccine
failure. The use of noninvasive stool measurements to evaluate EE, as
opposed to biopsy, also lends itself to application in future intervention-
al studies: identiﬁcation of biomarkers should make possible at-risk
stratiﬁcation and assessment of therapeutic response.
Oral vaccine failure and malnutrition affect more than one in four
children worldwide, and are not adequately addressed by currently
known interventions. This study, by better deﬁning clusters of charac-
teristics associated with malnutrition and vaccine failure, ﬁlls a knowl-
edge gap to allow rational design and testing of interventions.
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